News

Galena Biopharma Inc (NASDAQ:GALE) shares were up more than 19% on Tuesday to $2.16, nearing the top of its 52-week range at $2.39. Galena Biopharma Inc (NASDAQ:GALE) reported earnings per share of -$0.09 versus analysts estimates at -$0.06 at zero revenues. The company is focused on developing and commercializing targeted oncology...

Minerva Neurosciences Inc (NASDAQ:NERV) shares jumped 13.09% on June 1 to $13.91 after the company shared positive top-line results in clinical trials for its antidepressant drug candidate. Minerva Neurosciences Inc (NASDAQ:NERV) is a clinical-stage biopharmaceutical company that is focused on the development and commercialization of a portfolio of product candidates to treat...

NV5 Global Inc (NASDAQ:NVEE) shares advanced 10.39% to $30.08, showing stronger bullish momentum from last week's climb. NV5 Global Inc (NASDAQ:NVEE) shares are now at the top of the 52-week range of $15.00 to $30.21. The company has a market capitalization of $294.60 million at 8.28 million shares outstanding. It...

Celator Pharmaceuticals Inc (NASDAQ:CPXX) shares surged 71.59% to $30.08 on Tuesday after an acquisition announcement by Jazz Pharmaceuticals. Celator Pharmaceuticals Inc (NASDAQ:CPXX)  is an oncology-focused biopharmaceutical company engaged in developing products to improve patient outcomes in cancer. CombiPlex, its technology platform,  enables the design and evaluation of optimized combinations incorporating traditional...

Cliffs Natural Resources Inc (NYSE:CLF) shares jumped 38.80% to $4.32 on Tuesday following reports that the company will enter a new iron ore supply agreement. Cliffs Natural Resources Inc (NYSE:CLF) shares are moving in a 52-week range of $1.20 to $5.83, indicating significant momentum to test the top of its...